BioSpace News Archive

Drug Development

Cytokinetics Announces Continuation of COURAGE-ALS Following First Interim Analysis

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Data Monitoring Committee (DMC) for COURAGE-ALS recently convened to conduct the first planned interim analysis of this ongoing Phase 3 clinical trial which assessed for the potential of futility.

October 10, 2022
·
7 min read
Biotech Bay

Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy

Iovance Biotherapeutics, Inc. announced that the first patient was dosed, and completed the safety observation period, in the IOV-GM1-201 trial of Iovance’s genetically modified, PD-1 inactivated TIL therapy, IOV-4001.

October 10, 2022
·
7 min read
Deals

Immatics Announces $110 Million Underwritten Offering of Ordinary Shares

Immatics N.V. announced today that it has agreed to sell, by way of an underwritten public offering, 10,905,000 of its ordinary shares at a price of $10.09 per share.

October 10, 2022
·
4 min read
Business

Axonics® to Report Third Quarter 2022 Financial Results on October 31

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, will report third quarter 2022 financial results after the close of trading on Monday, October 31.

October 10, 2022
·
2 min read
BioMidwest

Oncology Specialists of Charlotte Partners with OneOncology

Oncology Specialists of Charlotte and OneOncology, a national platform for independent oncology practices, announced that the two organizations have finalized an agreement to partner to enhance the delivery of cancer care services to communities in and around Charlotte, North Carolina.

October 10, 2022
·
2 min read
First Wave BioPharma Presents Research Demonstrating Benefits of Improved Adrulipase Drug Delivery Formulation at AAPS 2022 PharmSci 360

First Wave BioPharma, Inc., announced today that research demonstrating key advantages of its improved adrulipase drug delivery formulation will be the subject of a poster presentation at AAPS 2022 PharmSci 360 on October 19 at 9:30 a.m.

October 10, 2022
·
6 min read
Pharm Country

Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022

Axsome Therapeutics, Inc. is joining the World Health Organization’s (WHO) 2022 World Mental Health Day campaign to make mental health and well-being for all a global priority.

October 10, 2022
·
5 min read
Genetown

Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System

Microbot Medical Inc. (Nasdaq: MBOT) is continuing to expand its global intellectual property portfolio for the LIBERTY ® Robotic System as a patent allowance was issued by the Israeli Patent Office, covering the LIBERTY Robotic System’s roll assembly mechanism.

October 10, 2022
·
2 min read
Genetown

Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas

Orchard Therapeutics today announced multiple presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), taking place October 11-14, 2022, in Edinburgh.

October 10, 2022
·
8 min read
Deals

Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing

Immunic, Inc. today announced it has entered into a securities purchase agreement (the " Purchase Agreement ") with select accredited investors and certain existing investors to issue and sell an aggregate of 8,696,552 shares of its common stock.

October 10, 2022
·
7 min read